“Use of Ranibizumab for the Treatment of Subretinal Neovascularization in Pathologic Myopia: A Prospective Study”. 2026. Ukrainian Journal of Ophthalmology , no. 3 (June): 10-14. https://doi.org/10.31288/oftalmolzh201631014.